Dr. Reddy’s delays semaglutide supplies over quality issues, causing shares to drop amid ongoing investigations and ...

Dr. Reddy’s Laboratories on Thursday said it has halted commercial supplies of its generic semaglutide after an issue associated with the active pharmaceutical ingredient (API) used in the drug and ...